Discover
PMN
ProMIS Neurosciences, Inc.
13.45
2 x 9.94
2 x 17.40
bid
ask
+
0.29
2.20%
2 @ 04:07 AM
13.08 -0.37 (2.75%)
| Ytd | 96.93% | |
| 1y | 9.80% |
12.40
day range
14.30
6.27
52 week range
39.75
| Open | 12.81 | Prev Close | 13.16 | Low | 12.40 | High | 14.30 | Mkt Cap | 120.62M |
| Vol | 63.01K | Avg Vol | 35.47K | EPS | -18.60 | P/E | N/A | Forward P/E | -1.51 |
| Beta | 0.61 | Short Ratio | 2.64 | Inst. Own | 50.31% | Dividend | N/A | Div Yield | N/A |
| Ex Div Date | N/A | Earning | 08-07 | 50-d Avg | 10.63 | 200-d Avg | 11.75 | 1yr Est | 7.65 |
PMN News
benzinga.com
12 Health Care Stocks Moving In Tuesday's Intraday Session
Gainers Creative Medical Tech (NASDAQ:CELZ) stock moved upwards by 242.5% to $2.77 during Tuesday&#
zacks.com
Wall Street Analysts See a 230.23% Upside in Promis Neurosciences (PMN): Can the Stock Really Move T
The mean of analysts' price targets for Promis Neurosciences (PMN) points to a 230.2% upside in the
benzinga.com
Cantor Fitzgerald Initiates Coverage On ProMIS Neurosciences with Overweight Rating
Cantor Fitzgerald analyst Pete Stavropoulos initiates coverage on ProMIS Neurosciences (NASDAQ:PM
benzinga.com
HC Wainwright & Co. Reiterates Buy on ProMIS Neurosciences, Maintains $18 Price Target
HC Wainwright & Co. analyst Raghuram Selvaraju reiterates ProMIS Neurosciences (NASDAQ:PMN) w
benzinga.com
HC Wainwright & Co. Reiterates Buy on ProMIS Neurosciences, Maintains $18 Price Target
HC Wainwright & Co. analyst Raghuram Selvaraju reiterates ProMIS Neurosciences (NASDAQ:PMN) w